MicroRNAs as Regulators, Biomarkers, and Therapeutic Targets in Autism Spectrum Disorder
Molecular Neurobiology · 2025
DOI: 10.1007/s12035-024-04582-x ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Neurobiology, 2025. Verfasst von Tong-Tong Yao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center On Translational Neuroscience, Institute of National Security, Minzu University of China, 27th South Zhongguancun Avenue, Beijing, 100081, Chi…. Hauptthemen laut MEDLINE: Autism Spectrum Disorder, MicroRNAs, Molecular Targeted Therapy. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 148 Literaturangaben. Gefördert von: Clinical Scientific Research Project of Chengdu Medical College - The Seventh People's Hospital of Chengdu, National Natural Science Foundation of China.
Abstract (Originalsprache)
The pathogenesis of autism spectrum disorder (ASD) is complex and is mainly influenced by genetic and environmental factors. Some research has indicated that environmental aspects may interplay with genetic aspects to enhance the risk, and microRNAs (miRNAs) are probably factors in explaining this link between heredity and the environment. MiRNAs are single-stranded noncoding RNAs that can regulate gene expression at the posttranscriptional level. Some research has indicated that miRNAs are closely linked to neurological diseases. Many aberrantly expressed miRNAs have been observed in autism, and these dysregulated miRNAs are expected to be potential biomarkers and provide new strategies for the treatment of this disease. This article reviews the research progress of miRNAs in autism, including their biosynthesis and function. It is found that some miRNAs show aberrant expression patterns in brain tissue and peripheral blood of autistic patients, which may serve as biomarkers of the disease. In addition, the article explores the novel role of exosomes as carriers of miRNAs with the ability to cross the blood-brain barrier and unique expression profiles, offering new possibilities for diagnostic and therapeutic interventions in ASD. The potential of miRNAs in exosomes as diagnostic markers for ASD is specifically highlighted, as well as the prospect of using engineered exosome-encapsulated miRNAs for targeted therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center On Translational Neuroscience, Institute of National Security, Minzu University of China, 27th South Zhongguancun Avenue, Beijing, 100081, China.
- School of Ethnology and Sociology, Minzu University of China, Beijing, China.
- Key Laboratory of Ethnomedicine of Ministry of Education, School of Pharmacy, Minzu University of China, Beijing, China.
- Department of Medical Laboratory, Affiliated Cancer Hospital of Chengdu Medical College, Chengdu Seventh People's Hospital, Chengdu, China. jiangzhongyong@cmc.edu.cn.
- Center On Translational Neuroscience, Institute of National Security, Minzu University of China, 27th South Zhongguancun Avenue, Beijing, 100081, China. yongcheng@muc.edu.cn.
- Center On Translational Neuroscience, College of Life and Environmental Sciences, Minzu University of China, Beijing, China. yongcheng@muc.edu.cn.
Förderung
- Clinical Scientific Research Project of Chengdu Medical College - The Seventh People's Hospital of Chengdu
- National Natural Science Foundation of China
Zitieren
APA
Yao, T. T., Chen, L., Du, Y., Jiang, Z. Y., & Cheng, Y. (2025). MicroRNAs as Regulators, Biomarkers, and Therapeutic Targets in Autism Spectrum Disorder. Molecular Neurobiology. https://doi.org/10.1007/s12035-024-04582-x
Vancouver
Yao TT, Chen L, Du Y, Jiang ZY, Cheng Y. MicroRNAs as Regulators, Biomarkers, and Therapeutic Targets in Autism Spectrum Disorder. Molecular Neurobiology. 2025. doi:10.1007/s12035-024-04582-x
BibTeX
@article{Yao2025,
author = {Yao, Tong-Tong and Chen, Lei and Du, Yang and Jiang, Zhong-Yong and Cheng, Yong},
title = {MicroRNAs as Regulators, Biomarkers, and Therapeutic Targets in Autism Spectrum Disorder},
journal = {Molecular Neurobiology},
year = {2025},
doi = {10.1007/s12035-024-04582-x}
}
EUVIMED